GenKyoTex
Leader in NOX therapies, based on the selective inhibition of NOX enzymes.
Launch date
Employees
Market cap
-
Enterprise valuation
$35m (Public information from Aug 2020)
Company register number 439489022
Archamps France (HQ)
Authorizing premium user...